1. Home
  2. Africa
  • News

Thinking outside the AIDS funding box

Cash - for generic use Nic McPhee/Flickr
Un indice solide doit être mis au point pour mesurer la qualité de l’aide apportée par les bailleurs, estiment les analystes
As traditional sources of financial aid dry up, new and innovative approaches to fundraising may be the best hope of generating money for HIV/AIDS efforts.

Fundraiser UNITAID has collected an estimated US$1.2 billion since 2006 for the treatment of HIV, tuberculosis and malaria, mainly from a small levy on airline tickets bought in 34 participating countries, most of them in Africa.

"With the current financial crisis it is going to be very difficult to achieve the MDGs [UN Millennium Development Goals] through official government aid, so innovative methods of financing the fight against these diseases must be sought," said Philippe Douste-Blazy, chair of UNITAID and a UN special advisor on innovative development financing at the first UNITAID implementers' meeting in the Kenyan capital, Nairobi, on 15 October.

A World Bank report in April projected that the global economic downturn could put the treatment of more than 1.7 million people in the developing world at risk by the end of 2009 through drug shortages, treatment interruptions and higher burdens of AIDS-related diseases.

According to Douste-Blazy, the airline levy gives participating developing nations an opportunity to contribute to treatment in their countries rather than depending on handouts from the developed world. "The idea is for funding not to move only from the North to the South, but also from the South to the South," he said.

Beth Mugo, Kenya's Minister for Public Health and Sanitation, told delegates it was time African governments played a bigger role in health financing. "We need long-term financing for health, and we must put pressure on our leaders to implement their Abuja pledge [made at an African Union Summit in the capital of Nigeria in 2001] to dedicate 15 percent of the budget to health," she said. "Few are doing so - in Kenya for example, only seven percent of our national budget is spent on health."

Cote d'Ivoire, Niger, Madagascar and Mauritius are applying the airline levy, while Benin, Burkina Faso and Kenya have said they will introduce it. The levy ranges from US$1 to $2 on economy-class tickets, and up to $40 on business- and first-class fares.

The funds are channelled through NGOs like the Clinton HIV/AIDS Initiative (CHAI), which has used the money to put 170,000 children in 38 countries on antiretroviral drugs (ARVs).

From 2010 individuals will be able to make a voluntary contribution of as little as US$2 when purchasing air tickets, booking hotel rooms or renting cars as part of a new initiative being launched by UNITAID in partership with the Millennium Foundation for Innovative Finance for Health, formed by the UN in 2008.

Strengthening African health systems

The meeting in Nairobi will discuss other ways in which UNITAID and its partner countries can finance the scale-up of HIV, tuberculosis and malaria treatment, but participants also stressed the urgent need for Africa's public health systems to become more efficient.

"In this part of the world we have weak public health systems; we have problems diagnosing these diseases, and when we do diagnose them we have difficulty finding qualified staff to treat patients," said David Okello, Kenya country representative for the UN World Health Organisation (WHO).

Read more:
 Action needed to avert "treatment time bomb"
 Governments must step up HIV funding, activists
 Seizure of drug shipment threatens ARV access
 How much bang for the PEPFAR buck?
There were also calls for greater efficiency in the approval and distribution of essential drugs across the continent. "When providing more drugs, we need to make sure that systems exist to ensure they reach the patients," Okello pointed out.

The UNAIDS country coordinator for Kenya, Erasmus Morah, argued that a single medicines agency for Africa would improve the efficiency of drug evaluation and supervision.

"This would replace the fragmented system that currently exists, put an end to manufacturers running from country to country to seek product approval, and reduce the time patients must wait for new drugs."

kr/ks/he

This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Get the day’s top headlines in your inbox every morning

Starting at just $5 a month, you can become a member of The New Humanitarian and receive our premium newsletter, DAWNS Digest.

DAWNS Digest has been the trusted essential morning read for global aid and foreign policy professionals for more than 10 years.

Government, media, global governance organisations, NGOs, academics, and more subscribe to DAWNS to receive the day’s top global headlines of news and analysis in their inboxes every weekday morning.

It’s the perfect way to start your day.

Become a member of The New Humanitarian today and you’ll automatically be subscribed to DAWNS Digest – free of charge.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join